Skip to main content
. 2012 Apr 4;95(5):1079–1088. doi: 10.3945/ajcn.111.027995

TABLE 2.

Subgroup analyses of mean change in BP1

Change in SBP
Change in DBP
Subgroup No. of trials Effect 95% CI P No. of trials Effect 95% CI P
mm Hg mm Hg mm Hg mm Hg
Hypertension
 Yes 13 −4.85 −7.50, −2.20 0.28 12 −1.67 −4.05, 0.72 0.85
 No 18 −3.11 −4.52, −1.71 17 −1.37 −3.10, 0.35
Diabetes
 Yes 5 −4.71 −8.73, −0.68 0.63 5 −4.06 −6.72, −1.40 0.08
 No 26 −3.70 −5.28, −2.11 24 −0.94 −2.45, 0.57
Baseline ascorbic acid
 <49.0 μmol/L 11 −4.95 −7.96, −1.93 0.28 11 −2.43 −5.30, 0.44 0.53
 ≥49.0 μmol/L 11 −3.09 −4.66, −1.52 11 −1.61 −2.82, −0.40
Mean age
 <50 y 12 −5.07 −7.22, −2.92 0.04 11 −2.44 −4.87, −0.01 0.19
 50–60 y 13 −3.59 −6.23, −0.94 12 −1.43 −3.99, 1.13
 >60 y 6 −1.85 −2.94, −0.77 6 0.03 −1.49, 1.55
Duration
 <8 wk 15 −2.89 −4.43, −1.36 0.43 15 −0.60 −2.15, 0.94 0.37
 ≥8 wk 16 −4.45 −6.63, −2.27 14 −2.34 −4.55, −0.14
Vitamin C dose
 <500 mg/d 6 −4.79 −7.25, −2.33 0.26 6 −2.96 −6.76, 0.85 0.72
 500 mg/d 11 −2.89 −4.50, −1.29 9 −0.27 −2.24, 1.71
 >500 mg/d 14 −2.96 −5.58, −0.34 14 −1.50 −3.56, 0.56
Study design
 Crossover 9 −2.96 −4.34, −1.57 0.51 7 −0.10 −1.59, 1.39 0.17
 Parallel 22 −4.17 −6.27, −2.07 22 −2.07 −3.91, −0.23
Vitamin C administered as the only intervention
 Yes 16 −2.59 −3.81, −1.38 0.06 16 −0.52 −2.07, 1.04 0.12
 No 15 −4.98 −7.30, −2.65 13 −2.73 −5.03, −0.42
Antihypertensive medication use
 Yes 15 −3.58 −5.78, −1.37 0.79 14 −0.78 −2.68, 1.12 0.41
 No 16 −3.93 −5.86, −2.00 15 −2.01 −3.84, −0.18
No. of BP measurements
 1–2 10 −4.02 −5.57, −2.47 0.01 10 −2.37 −4.64, −0.10 0.05
 3–4 10 −3.46 −6.01, −0.90 8 −1.28 −2.90, 0.35
 60–66 (ABPM) 3 −1.69 −2.75, −0.62 3 1.38 −1.17, 3.93
Trial size
 <38 participants 14 −2.76 −4.60, −0.91 0.12 12 0.49 −1.48, 2.47 0.01
 ≥38 participants 17 −4.68 −6.74, −2.63 17 −2.69 −4.49, −0.88
1

If a trial reported effects in 2 distinct subgroups, it was counted twice. As a result, the total number may exceed the 29 trials included in the primary analysis. P represents whether or not the groups were different and was determined by meta-regression of the subgroups. ABPM, ambulatory blood pressure monitoring; BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure.